NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

David, I don't know the answer why it was not updated earlier but I am guessing that NWBO would have been accused for the last 18 months of changing the endpoints after data lock because supposedly NWBO knew that the trial had failed.
Last Tuesday's presentation showed that the trial is a success and shortly thereafter NWBO requested an update of clinicaltrial.gov. The wolf pack can always invent false arguments that are used to attack the company. This has been NWBO's history for many years now.

I do believe that we may shortly see:
1. Dr. Bosch's presentation at ASCO
2. This June U. Penn University's information about patient's immunological marker responses or lack thereof in the trial's patients.
3. TLD
4. Publication

I have no idea in what order 1, 2, 3, and 4 will appear.